###begin article-title 0
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Genetic variation in the methylenetetrahydrofolate reductase gene, MTHFR, does not alter the risk of visual failure in Leber's hereditary optic neuropathy
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
Focal neurodegeneration of the optic nerve in Leber hereditary optic neuropathy (LHON) is primarily due to a maternally inherited mitochondrial DNA mutation. However, the markedly reduced penetrance of LHON and segregation pattern of visual failure within families implicates an interacting nuclear genetic locus modulating the phenotype. Folate deficiency is known to cause bilateral optic neuropathy, and defects of folate metabolism have been associated with nonarteritic ischemic optic neuropathy.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Methylenetetrahydrofolate reductase (MTHFR) catalyzes a critical step in folate metabolism, and genetic variation in MTHFR has been associated with several late-onset neurodegenerative diseases.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
We therefore determined whether functional genetic variants in MTHFR could account for the reduced penetrance in LHON by studying 414 LHON mtDNA mutation carriers. We found no evidence of association between visual failure in LHON and MTHFR polymorphisms or the MTHFR haplotype.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Genetic variation in MTHFR does not provide an explanation for the variable phenotype in LHON.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 808 809 808 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 948 949 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1097 1098 1097 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1099 1100 1099 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1188 1189 1188 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 730 738 <span type="species:ncbi:9606">patients</span>
Leber hereditary optic neuropathy (LHON; OMIM ) is a common cause of inherited blindness that typically presents with bilateral, painless, subacute vision failure in young adult males. Affected individuals develop focal degeneration of the optic nerve and present clinically with impaired color vision (dyschromatopsia), a dense visual field defect (central or cecocentral scotoma), and abnormal visual electrophysiology due to primary retinal ganglion cell loss [1]. The diagnosis is usually confirmed by molecular genetic analysis for one of three common mitochondrial DNA (mtDNA) mutations which all affect genes coding for complex I subunits of the respiratory chain: m.3460G>A, m.11778G>A, and m14484T>C. However, only a few patients harboring a pathogenic LHON mtDNA mutation develop visual failure [2,3]. Segregation analysis of LHON pedigrees indicated a two-locus model: a mtDNA mutation as one locus and a modulating X-chromosomal locus [4]. Although an interacting X-chromosomal locus could explain the gender bias in LHON, not all pedigrees with LHON show linkage to the X-chromosome [5-7], and the segregation pattern in some pedigrees implicates one or more autosomal loci [8]. However, attempts to identify a nuclear modifying gene by both genetic mapping and functional genomics have so far failed to identify the interacting nuclear genes.
###end p 11
###begin p 12
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
Folate is a necessary component for cellular maintenance and growth, especially important during early embryonic development, where it is involved in DNA synthesis. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a critical step in the remethylation of homocysteine (Hcy) to methionine. Genetic variants in MTHFR are associated with hyperhomocysteinemia and cardiovascular disease [9] and are also associated with neural tube defects in the fetus [10]. c.677C>T, present at approximately 33%-37% heterozygously and roughly 10% homozygously in Europeans, leads to a substitution of alanine to valine (at position 222) in the catalytic domain of MTHFR, and subsequent reduction in enzyme activity [11]. This effect is magnified when c.677C>T is found as a compound heterozygote with homozygous c.1298A>C [12,13].
###end p 12
###begin p 13
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
Previous studies have shown a link between oxidative stress and increased Hcy in neurodegenerative disorders [14,15], with a pronounced increase in Hcy in homozygote c.677C>T Alzheimer disease [16] and Parkinson disease [17]. Elevated levels of Hcy have been shown to cause endothelial dysfunction by increasing oxidative stress or impairing nitric oxide metabolism [18,19]. Increased Hcy was shown to induce apoptotic death in retinal ganglion cells, hypothesized as a cause of LHON [20], by overstimulation of the N-methyl-D-aspartate receptors and caspase-3 activation [21].
###end p 13
###begin p 14
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Increased Hcy, but not the c.677C>T variation, was identified as a risk factor in nonarteritic ischemic optic neuropathy and central retinal vein occlusion [22,23]. Folate deficiency is known to cause bilateral optic neuropathy [24,25]. Evidence is accumulating that implicates folate metabolism in optic neuropathies, particularly those affecting the retinal ganglion cell, making MTHFR a strong autosomal candidate genetic modifier in LHON, despite not localizing to the X chromosome and therefore less likely to contribute directly to the gender bias in LHON.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 732 737 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
We studied 12 common nonsynonymous MTHFR () single nucleotide polymorphisms (SNPs): (, , , , , , , , , , , and ) in a European cohort of 414 LHON mtDNA mutation carriers (182 affected, 232 unaffected). All subjects were recruited from two European centers with local ethical review board approval in accordance with the declaration of Helsinki. 70% of the attached individuals were male, and 41% of the unaffected individuals were male, in keeping with the gender bias that characterizes LHON. All were homoplasmic for m.3460G>A, m.11778G>A, or m14484T>C.  corresponds to c.677C>T, and  corresponds to c.1298A>C. The additional ten SNPs were selected using the following criteria: 1) nonsynonymous substitutions predicted to affect MTHFR function; and 2) present in control subjects at >0.1% () [26].
###end p 16
###begin p 17
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTND</italic>
###xml 208 220 <span type="species:ncbi:9606">participants</span>
The clinical phenotype was determined by a local ophthalmologist [1] and the genetic diagnosis was confirmed in affected individuals by mtDNA direct sequencing of the MTND genes or PCR-RFLP analysis. Control participants (unaffected mutation carriers) had no visual symptoms and were older (>30 years) than the median age of onset for LHON (24 years). The frequency of sequence variants was determined in European controls by primer extension of multiplex polymerase chain reaction products with the detection of the allele-specific extension products by matrix-associated laser desorption/ionization time of flight (MALDITOF; Sequenom, San Diego, CA) mass spectrometry. Genotype and allelic associations were compared using SPSS v15.0 using Fishers exact test. The p values given are two-tailed. To correct for multiple testing bias, we performed permutation testing using . Statistical power calculation is available at .
###end p 17
###begin title 18
Results
###end title 18
###begin p 19
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 576 583 576 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
We analyzed SNP frequencies in 12 non-synonymous SNPs in a large LHON cohort. Six of the SNPs (, , , , , and ) showed no variation and were removed from any further analysis. When males and females were considered together, Fisher exact test revealed a weak association between  and LHON (Table 1, p=0.030). When males and females were considered separately (Table 2),  was associated with visual failure in male LHON patients (p=0.043), When different LHON mutations were studied separately, we observed a significant association between  and both m.3460 G>A and m.14484T>C (Table 3, p=0.018 and 0.028 respectively). However none of these associations were significant after correcting for multiple testing bias using permutation testing.
###end p 19
###begin title 20
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Non-synonymous MTHFR variants in LHON.
###end title 20
###begin p 21
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Comparison of MTHFR variant genotype and allele frequencies between LHON patients (A) and controls (C; where WT and MT are homozygous wild-type and mutant, respectively and Het is heterozygous. P is an uncorrected Pearson's chi-square probability).
###end p 21
###begin title 22
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
Gender specific MTHFR variants in LHON.
###end title 22
###begin p 23
###xml 91 99 <span type="species:ncbi:9606">patients</span>
Comparison of c.677C>T and c.1298A>C (rs1801133:rs1801131) compound genotypes between LHON patients (A) and controls (C). P is an uncorrected Pearson's chi-square probability).
###end p 23
###begin title 24
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
LHON mutation specific MTHFR variation
###end title 24
###begin p 25
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Comparison of LHON mutation specific MTHFR variant genotype and allele frequencies between LHON patients (A) and controls (C) where WT and MT are homozygous wild-type and mutant respectively and Het is heterozygous. P is an uncorrected Pearson's chi-square probability.
###end p 25
###begin p 26
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
When combining complex SNPs into complex genotypes we found no association to a compound genotype of c.677C>T and c.1298A>C (:; Table 4). We also performed six locus haplotyping analysis. There was no significant difference in the frequency of each genotype between affected and unaffected.
###end p 26
###begin title 27
c.677C>T and c.1298A>C complex genotypes in LHON
###end title 27
###begin p 28
###xml 91 99 <span type="species:ncbi:9606">patients</span>
Comparison of c.677C>T and c.1298A>C (rs1801133:rs1801131) compound genotypes between LHON patients (A) and controls (C). P is an uncorrected Pearson's chi-square probability).
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 703 708 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
We found no statistically robust association between any of the 12 functional MTHFR SNPs, individually or as complex genotypes, and vision failure in LHON families, or when affected individuals were compared to controls. It is intriguing that specific SNPs appeared to be associated with vision failure when considered in subgroup analyses separating the different LHON mtDNA mutations and different genders, but these associations did not stand up to the rigors of a correction for multiple significance testing. We therefore interpreted our findings conservatively, but larger studies may show that these associations are pathophysiologically relevant. Although we cannot exclude the possibility that MTHFR contributes to the pathophysiology of LHON, our findings indicate that the gene is unlikely to be the major nuclear genetic modifier interacting with the primary mtDNA mutations. Genes encoding other enzymes involved in folate metabolism may be relevant, as could dietary intake of folate. Biochemical and epidemiological studies would address these issues. Further genetic studies on a genome-wide level are required to define the nuclear-mitochondrial interaction in LHON.
###end p 30
###begin title 31
Acknowledgments
###end title 31
###begin p 32
We are grateful to the clinicians who sent DNA samples and clinical data. PFC is a Wellcome Trust Senior Fellow in Clinical Science. PFC also receives funding from Ataxia (UK), the Parkinson Disease Society (UK), and the Medical Research Council (UK).
###end p 32
###begin title 33
References
###end title 33
###begin article-title 34
Ophthalmic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations.
###end article-title 34
###begin article-title 35
Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations.
###end article-title 35
###begin article-title 36
The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11 778 mutation.
###end article-title 36
###begin article-title 37
X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: Evidence from segregation analysis for dependence on X chromosome inactivation.
###end article-title 37
###begin article-title 38
Preliminary exclusion of an X-linked gene in Leber optic atrophy by linkage analysis.
###end article-title 38
###begin article-title 39
Meiotic breakpoint mapping of a proposed X linked visual loss susceptibility locus in Leber's hereditary optic neuropathy.
###end article-title 39
###begin article-title 40
Evidence against an X-linked locus close to DXS7 determining visual loss susceptibility in British and Italian families with Leber hereditary optic neuropathy.
###end article-title 40
###begin article-title 41
Inherited Mitochondrial Optic Neuropathies.
###end article-title 41
###begin article-title 42
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition.
###end article-title 42
###begin article-title 43
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida.
###end article-title 43
###begin article-title 44
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.
###end article-title 44
###begin article-title 45
MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians.
###end article-title 45
###begin article-title 46
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.
###end article-title 46
###begin article-title 47
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
###end article-title 47
###begin article-title 48
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients.
###end article-title 48
###begin article-title 49
Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease.
###end article-title 49
###begin article-title 50
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.
###end article-title 50
###begin article-title 51
Acute hyperhomocysteinaemia and endothelial dysfunction.
###end article-title 51
###begin article-title 52
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase.
###end article-title 52
###begin article-title 53
Leber Hereditrary Optic Neruopathy: mitochondrial mutations and degenration of the optic nerve.
###end article-title 53
###begin article-title 54
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine.
###end article-title 54
###begin article-title 55
Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy.
###end article-title 55
###begin article-title 56
Hyperhomocysteinemia: a risk factor for central retinal vein occlusion.
###end article-title 56
###begin article-title 57
Folate-responsive optic neuropathy.
###end article-title 57
###begin article-title 58
Optic neuropathy from folic acid deficiency without alcohol abuse.
###end article-title 58
###begin article-title 59
dbSNP: the NCBI database of genetic variation.
###end article-title 59

